Title
Category
Credits
Event date
Cost
  • Gastrointestinal
  • Oncology
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Please Note: Credit Is No Longer Available The implementation of molecular testing, especially analysis of human epidermal growth factor receptor 2 (HER2) status, has had a significant impact on clinical practice and patient care. Join Drs. David Ilson and Michael Press for this on-demand online activity, as they discuss assessment of HER2-mutant disease from each of their unique perspectives.Supported through an independent educational grant from AstraZeneca and Daiichi Sankyo. 
  • Oncology
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • Participation
$0.00
Please Note: Credit Is No Longer Available As the treatment paradigm for bladder cancer continuously evolves, all members of the oncology healthcare team must be equipped to evolve with it to ensure optimal patient care. With this evolution comes many questions for the bladder cancer treatment team. Join Drs. Neal Shore, Arjun Balar, Lidia Lopez, and Nurse Joanie Pfahl as they examine the new paradigm of bladder treatment using ICIs, and discuss the important role of each person on the treatment team.
  • Gastrointestinal
  • Oncology
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Please Note: Credit Is No Longer Available 
  • Gastrointestinal
  • Oncology
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Please Note: Credit Is No Longer AvailableAntibody-drug conjugates or “ADCs” are a novel class of highly potent biopharmaceutical drug composed of an antibody linked, via a chemical linker, to a biologically active drug or cytotoxic compound. Nearly 150 investigational ADCs are currently in pre-clinical and clinical trials. Join Drs. David Ilson and Kohei Shitara as they discuss emerging data from select clinical trials evaluating combinations of HER2-targeted therapies for patients with gastric cancer.
  • Oncology
  • Pulmonology
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Please Note: Credit Is No Longer Available Medical Moment One: Expert Insight on Practical Aspects of Molecular Profiling for Early-Stage NSCLC Cancers 
  • Oncology
  • Pulmonology
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Please Note: Credit Is No Longer Available Medical Moment Two: Expert Insight on Applying the ADAURA Results to Treatment of Early-Stage NSCLC Patients 
  • Hematology
  • Oncology
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
This Medical Moments webinar will review all clinically relevant aspects of cancer-related anemia (CRA) management, including chemotherapy-induced anemia (CIA). The activity will begin with a brief primer on iron metabolism and absorption principles, including the practical distinctions between absolute and functional iron deficiency, and the impact of that distinction on treatment approaches.
  • Cardiology
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Please Note: Credit Is No Longer Available Initiating and optimizing in-hospital guideline-directed medical therapies (GDMT) remains a challenge for clinicians treating patients with worsening HFrEF. Join Drs. Muthiah Vaduganathan and Michelle Kittleson, as they discuss opportunities and strategies to employ evidence-based therapies to address these challenges.Supported through an independent educational grant from Merck.
  • Cardiology
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Please Note: Credit Is No Longer Available Heart failure is a major public-health problem resulting in substantial morbidity and mortality for the US. Unfortunately, challenges and barriers to effective use of guideline-directed medical therapies (GDMT) among hospitalized patients with HFrEF remain. Join Drs. Muthiah Vaduganathan and Amulya Nagarur as they discuss practical strategies and insights into using GDMT, and opportunities for multidisciplinary partnerships when treating these patients.
  • Cardiology
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Please Note: Credit Is No Longer Available Join Drs. Muthiah Vaduganathan and Javed Butler for this on-demand online activity, as they examine novel methodologies to address the clinical worsening of HFrEF, with a focus on recently-reported results from the VICTORIA trial.Supported through an independent educational grant from Merck.